Arcutis Biotherapeutics Inc share price logo

Arcutis Biotherapeutics Inc

NASDAQ: ARQT

Mid Cap

$21.23

-0.72

(-3.28%)

as on

Arcutis Biotherapeutics Inc Stock Performance

as on June 6, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $21.03
    $22.19
    downward going graph

    0.94%

    Downside

    4.52%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $12.72
    $31.77
    downward going graph

    40.08%

    Downside

    49.65%

    Upside

    downward going graph

Arcutis Biotherapeutics Inc share price movements today

Previous Close
$21.95
Open
$21.93
Volume
1.0M
Day's Low - High
$21.03 - $22.19
52 Week Low - High
$12.72 - $31.77

Arcutis Biotherapeutics Inc Historical Returns

1 Month Return
-6.28 %
3 Month Return
-8.43 %
1 Year Return
+ 62.47 %
3 Year Return
+ 156.43 %
5 Year Return
-16.79 %

Arcutis Biotherapeutics Inc Stock Fundamentals & Key Indicators

Check Arcutis Biotherapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.6B

EPS (TTM)

0.245

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

5.5M

Revenue (TTM)

415.6M

Profit Margin

-0.57%

Return On Equity TTM

-1.43%

Arcutis Biotherapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Arcutis Biotherapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$2.6B-16.79%NA-0.57%NA
BUY$32.2B410.63%NA0.00%NA
BUY$39.1B108.54%73.5112.55%NA
BUY$108.7B110.42%25.4535.51%NA
BUY$64.9B22.83%15.1129.65%0.59%

Stock Returns calculator for Arcutis Biotherapeutics Inc Stock including INR - Dollar returns

The Arcutis Biotherapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Arcutis Biotherapeutics Inc investment value today

Current value as on today

₹1,74,165

Returns

₹74,165

(+74.16%)

Returns from Arcutis Biotherapeutics Inc Stock

₹57,143 (+57.14%)

Dollar Impact

₹17,022 (+17.02%)

Analyst Recommendation on Arcutis Biotherapeutics Inc Stock

Based on 13 analysts

BUY

76.92%

Buy

23.08%

Hold

0.00%

Sell

Based on 13 analysts, 76.92% of analysts recommend a 'BUY' rating for Arcutis Biotherapeutics Inc. Average target price of $34.62

Arcutis Biotherapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Arcutis Biotherapeutics Inc.

What analysts predicted

38.68%UPSIDE

Target Price

$34.62

Current Price

$21.23

Analyzed by

13 Analysts

Target

$34.62

Arcutis Biotherapeutics Inc target price $34.62, a slight upside of 38.68% compared to current price of $21.23. According to 13 analysts rating.

Indian Investors' Interest in Arcutis Biotherapeutics Inc Stock

Search interest for Arcutis Biotherapeutics Inc Stock has increased by 34% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:34% versus previous 30 day period

Arcutis Biotherapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
13
49
30
44
71
65
81
99
129
105
Gross Profit
11
46
27
39
64
57
74
90
117
95
Operating Income
-61
-31
-50
-39
-7
-24
-14
8
18
-9
EBITDA
-58
-27
-44
-33
-4
-18
-11
11
22
-8
Interest Expense
7
7
7
6
5
2
3
3
3
4
Depreciation
0
0
0
1
0
3
0
0
0
0
Income Before Tax
-66
-35
-52
-41
-10
-24
-15
7
17
-11
Income Tax Expense
0
0
0
-
0
0
0
0
0
0
Net Income
-66
-35
-52
-41
-10
-25
-15
7
17
-11
Net Profit Margin
-490.05%
-71.38%
-169.59%
-92.81%
-15.12%
-38.06%
-19.49%
7.47%
13.43%
-10.72%

Arcutis Biotherapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
3
59
196
376
Gross Profit
-
-
0
0
0
2
54
177
339
Operating Income
-4
-19
-43
-136
-206
-301
-241
-128
-12
EBITDA
-4
-19
-41
-135
-206
-294
-227
-109
2
Interest Expense
-
-
-
-
0
15
29
27
12
Depreciation
-
-
0
0
0
0
1
2
4
Income Before Tax
-4
-19
-41
-135
-206
-311
-259
-139
-14
Income Tax Expense
-4
0
0
0
0
9
3
0
1
Net Income
-4
-19
-41
-135
-205
-311
-262
-140
-16
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-8449.76%
-439.79%
-71.25%
-4.29%

Arcutis Biotherapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-35
-52
-41
-10
-25
-15
7
17
-11
Operating Cash Flow
-31
-45
-34
0
-30
0
-1
26
2
Investing Cash Flow
-28
-62
84
34
11
17
-25
-34
-11
Financing Cash Flow
161
1
0
-97
0
1
1
3
1
Change in Cash
101
-105
50
-63
-18
19
-25
-4
-8

Arcutis Biotherapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-19
-41
-135
-206
-311
-262
-140
-16
Operating Cash Flow
-14
-42
-113
-174
-257
-247
-112
-5
Investing Cash Flow
-11
-26
-181
-75
-87
180
28
-30
Financing Cash Flow
61
93
298
281
301
101
66
6
Change in Cash
35
23
3
31
-43
34
-17
-28

Global Institutional Holdings in Arcutis Biotherapeutics Inc

Funds
Holdings
Jennison Associates LLC
3.98%
Pivotal bioVenture Partners Investment Advisor LLC
1.71%
HHG PLC
1.48%
Point72 Asset Management, L.P.
1.24%
The Goldman Sachs Group Inc
1.28%

Arcutis Biotherapeutics Inc News & Key Events

  • img

    Today's Timeline - 17 December

    Wed, 10:30 PM

    -

    Arcutis Biotherapeutics reports strong performance of Zoryve, boosting sales through consistent label expansion.

    Thu, 04:28 AM

    -

    Insider sold shares worth $332,851, according to a recent SEC filing.

Insights on Arcutis Biotherapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 263.2% return, outperforming this stock by 215.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 454.6% return, outperforming this stock by 334.1%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 129.50M → 105.39M (in $), with an average decrease of 18.6% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 17.39M → -11.29M (in $), with an average decrease of 164.9% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, ARQT stock has moved down by -32.0%

About Arcutis Biotherapeutics Inc

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a potent and highly selective checkpoint agonist of the CD200 receptor. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.
OrganisationArcutis Biotherapeutics Inc
Headquarters3027 Townsgate Road, Westlake Village, CA, United States, 91361
IndustryBiotechnology
CEOMr. Todd Franklin Watanabe M.A.
E-voting on sharesClick here to vote

Key Management of Arcutis Biotherapeutics Inc

Name

Title

Mr. Todd Franklin Watanabe M.A.

President, CEO & Director

Mr. Larry Todd Edwards

Executive VP & Chief Commercial Officer

Mr. Steve Arias

Vice President of Compliance & Privacy

Ms. Amanda Sheldon

Head of Corporate Communications

Ms. Aleen Hosdaghian

Vice President of Marketing

Dr. Bhaskar Chaudhuri Ph.D.

Co-Founder & Director Emeritus

Ms. Latha Vairavan

Senior VP & Chief Financial Officer

Mr. Masaru Matsuda Esq., J.D.

Executive VP, Chief Legal Officer & Corporate Secretary

Dr. Patrick E. Burnett M.D., Ph.D.

Executive VP & Chief Medical Officer

Mr. Brian Schoelkopf

Head of Investor Relations

FAQs

What is Arcutis Biotherapeutics Inc share price today?

Arcutis Biotherapeutics Inc share price today is $21.23 as on at the close of the market. Arcutis Biotherapeutics Inc share today touched a day high of $22.19 and a low of $21.03.

What is the 52 week high and 52 week low for Arcutis Biotherapeutics Inc share?

Arcutis Biotherapeutics Inc share touched a 52 week high of $31.77 on and a 52 week low of $12.72 on . Arcutis Biotherapeutics Inc stock price today i.e. is closed at $21.23,which is 33.18% down from its 52 week high and 66.90% up from its 52 week low.

What is Arcutis Biotherapeutics Inc's market capitalisation today?

Arcutis Biotherapeutics Inc market capitalisation is $0.00T as on .

How to invest in Arcutis Biotherapeutics Inc Stock (ARQT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Arcutis Biotherapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Arcutis Biotherapeutics Inc Shares that will get you 0.0707 shares as per Arcutis Biotherapeutics Inc share price of $21.23 per share as on June 6, 2026 at 8:46 am IST.

What is the minimum amount required to buy Arcutis Biotherapeutics Inc Stock (ARQT) from India?

Indian investors can start investing in Arcutis Biotherapeutics Inc (ARQT) shares with as little as ₹94.95 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in Arcutis Biotherapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Arcutis Biotherapeutics Inc share’s latest price of $21.23 as on June 6, 2026 at 8:46 am IST, you will get 0.4710 shares of Arcutis Biotherapeutics Inc. Learn more about fractional shares .

What are the returns that Arcutis Biotherapeutics Inc has given to Indian investors in the last 5 years?

Arcutis Biotherapeutics Inc stock has given -16.79% share price returns and 31.56% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?